Cashu
Investor Pressure on Avadel Pharmaceuticals: Lessons for Jazz Pharmaceuticals in Board Governance
2 days ago
Stocks
Health Care
jazz
Jazz Pharmaceuticals plc
JAZZ
-0.47 (-0.43%)
109.45
USD
At close at Jul 04, 20:37 UTC
Overview
Loading chart...
Key Stats
Market Cap
6.65B
Dividend Yield
0.00%
P/E Ratio
13.79
EPS
9.08
Revenue
4.07B
Avg. Volume
1.10M
About
What does JAZZ do?
Jazz Pharmaceuticals Plc, headquartered in Dublin, focuses on developing treatments for narcolepsy, oncology, pain, and psychiatry, employing 2,800 staff since its IPO in 2012. Key products include Xywav, Xyrem, and Defitelio.
Join our newsletter to keep up to date with us!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.